The estimated penetrance of BRCA1 mutation carriers by age 70 was 65% for BC and 45% for ovarian cancer, and the corresponding rates of BRCA2 mutation carriers were 45% and 11% [6]. The gene discussed is BRCA2; the disease is breast cancer.